Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
WHIM syndrome is an immunodeficiency disease characterized by neutropenia, hypogammaglobulinemia and extensive human papillomavirus (HPV) infection. Despite the peripheral neutropenia, bone marrow aspirates from affected individuals contain abundant mature myeloid cells, a condition termed myelokathexis. The susceptibility to HPV is disproportionate compared with other immunodeficiency conditions, suggesting that the product of the affected gene may be important in the natural control of this infection. We describe here the localization of the gene associated with WHIM syndrome to a region of roughly 12 cM on chromosome 2q21 and the identification of truncating mutations in the cytoplasmic tail domain of the gene encoding chemokine receptor 4 (CXCR4). Haplotype and mutation analyses in a pedigree transmitting myelokathexis as an apparently autosomal recessive trait support genetic heterogeneity for this aspect of the WHIM syndrome phenotype. Lymphoblastoid cell lines carrying a 19-residue truncation mutation show significantly greater calcium flux relative to control cell lines in response to the CXCR4 ligand, SDF-1, consistent with dysregulated signaling by the mutant receptor. The identification of mutations in CXCR4 in individuals with WHIM syndrome represents the first example of aberrant chemokine receptor function causing human disease and suggests that the receptor may be important in cell-mediated immunity to HPV infection.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Alterations in GPCR signalling are implicated in the pathogenesis and treatment of neuropsychiatric55, immunological56, gastrointestinal57,58, cardiac59, renal, hormonal, infectious60 and many other disorders53,54.”
From Unexplored therapeutic opportunities in the human genome (2018) · cites this paper as [56]
Citations
Cites
Involvement of chemokine receptors in breast cancer metastasis
Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340
HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor
Feng, Y., Broder, C. C., Kennedy, P. E., & Berger, E. A. (1996) · Science · doi:10.1126/science.272.5263.872 · Cited by 4,172
Identification of a major co-receptor for primary isolates of HIV-1
Deng, H., Liu, R., Ellmeier, W., Choe, S., Unutmaz, D., Burkhart, M., Marzio, P. D., Marmon, S., Sutton, R. E., Hill, C. M., et al. (1996) · Nature · doi:10.1038/381661a0 · Cited by 3,641 · cited 1×
“To date, their role in disease causation has been best established for the co-receptor function of CCR5 and CXCR4 in HIV infectio”
BackgroundParametric and nonparametric linkage analysis: a unified multipoint approach.
Kruglyak, L., Daly, M. J., Daly, M. J., & Lander, E. S. (1996) · PubMed · Cited by 2,877
Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development
Zou, Y.-R., Kottmann, A. H., Kuroda, M., Taniuchi, I., & Littman, D. R. (1998) · Nature · doi:10.1038/31269 · Cited by 2,489
Nagasawa, T., Hirota, S., Tachibana, K., Takakura, N., Nishikawa, S.-I., Kitamura, Y., Yoshida, N., Kikutani, H., & Kishimoto, T. (1996) · Nature · doi:10.1038/382635a0 · Cited by 2,338
Ma, Q., Jones, D., Borghesani, P. R., Segal, R. A., Nagasawa, T., Kishimoto, T., Bronson, R. T., & Springer, T. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9448 · Cited by 1,682
The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract
Tachibana, K., Hirota, S., Iizasa, H., Yoshida, H., Kawabata, K., Kataoka, Y., Kitamura, Y., Matsushima, K., Yoshida, N., Nishikawa, S.-I., et al. (1998) · Nature · doi:10.1038/31261 · Cited by 1,525
Multilocus linkage analysis in humans: detection of linkage and estimation of recombination.
Lathrop, M. G., Lalouel, J.-M., Julier, C., & Ott, J. (1985) · Europe PMC (PubMed Central) · Cited by 1,228
Burger, J. A., Tsukada, N., Burger, M., Zvaifler, N. J., Dell'Aquila, M., & Kipps, T. J. (2000) · Blood · doi:10.1182/blood.v96.8.2655 · Cited by 607 · cited 1×
“Moreover, CXCR4 and SDF-1 signaling has been shown to inhibit spontaneous apoptosis in human chronic lymphocytic leukemia B cell”
Background
Cited by
Items 301–400 of 724
Proteolytic processing of human serum albumin generates EPI-X4, an endogenous antagonist of CXCR4
Zirafi, O., Hermann, P. C., & Münch, J. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.2mr1115-521rr · Cited by 29
“However, the inverse agonist activity of EPI-X4 could be of advantage in the treatment of diseases associated with hyperactivated CXCR4, such as the WHIM syndrome [14] or Waldenström macroglobulinemia [28].”
BackgroundFutahashi, Y., Komano, J. A., Urano, E., Aoki, T., Hamatake, M., Miyauchi, K., Yoshida, T., Koyanagi, Y., Matsuda, Z., & Yamamoto, N. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00388.x · Cited by 36
Moens, L., Frans, G., Bosch, B., Bossuyt, X., Verbinnen, B., Poppe, W. A. J., Boeckx, N., Slatter, M. A., Brusselmans, C., Díaz, G. A., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.04.057 · Cited by 28
“(1) All authors were responsible for the conception and design of the study, 211”
BackgroundCharacterization, Dynamics, and Mechanism of CXCR4 Antagonists on a Constitutively Active Mutant
Rosenberg, E., Harrison, R. E. S., Tsou, L., Drucker, N., Humphries, B. A., Rajasekaran, D., Luker, K., Wu, C.-H., Song, J.-S., Wang, C.-J., et al. (2019) · Cell Chemical Biology · doi:10.1016/j.chembiol.2019.01.012 · Cited by 26
“Mutants at the C-terminal region of the CXCR4 lead to Warts, Hypogammaglobulinemia, Immunodeficiency, and Myelokathexis (WHIM) syndrome through a gain of function mechanism (Hernandez et al., 2003).”
BackgroundBonaud, A., Lemos, J. P., Espéli, M., & Balabanian, K. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.658535 · Cited by 34
García‐Cuesta, E. M., Rodríguez-Frade, J. M., Gardeta, S. R., D’Agostino, G., Martínez, P., Palacios, B. S., Cascio, G., Wolf, T., Mateos, N., Ayala-Bueno, R., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2119483119 · Cited by 31
“Typically, mutations cause premature termination or a frameshift in the region that encodes the cytoplasmic tail of the protein, which is important for signaling (2, 3).”
BackgroundSevere congenital neutropenia: new genes explain an old disease
Bohn, G., Welte, K., & Klein, C. (2007) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e3282f05cc2 · Cited by 32
A 55-year-old man with hypogammaglobulinemia, lymphopenia, and unrelenting cutaneous warts
Lynn, J., Knight, A. K., Kamoun, M., & Levinson, A. I. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.02.033 · Cited by 28
Advances in asthma, allergy and immunology series 2004: basic and clinical immunology.
Chinen, J., & Shearer, W. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.05.036 · Cited by 32
Simons, B. D., & Karin, O. (2024) · Immunity · doi:10.1016/j.immuni.2024.02.005 · Cited by 34
Approach to the Patient with Recurrent Infections
Ballow, M. C. (2009) · Elsevier eBooks · doi:10.1016/b978-0-323-05659-5.00080-2 · Cited by 27
Defects of leukocyte migration in primary immunodeficiencies
Badolato, R. (2013) · European Journal of Immunology · doi:10.1002/eji.201243155 · Cited by 27
Gómez‐Moutón, C., Fischer, T., Peregil, R. M., Jiménez-Baranda, S., Stossel, T. P., Nakamura, F., & Mañes, S. (2014) · Blood · doi:10.1182/blood-2014-09-601807 · Cited by 27
“We base this conclusion on the observations that (1) recombinant FLNA repeats 19 and/or 23 bound in vitro with high affinity to a synthetic peptide representing ICL3, (2) truncation of the ICL3 FLNA-binding motif severely inhibited FLNA association with CXCR4 in cells, (3) deletion of the ICL3 FLNA-binding motif accel…”
BackgroundRare Genetic Blood Disease Modeling in Zebrafish
Rissone, A., & Burgess, S. M. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00348 · Cited by 30
“This leads to a defect in the internalization of the CXCR4 receptor after the binding to the sdf1 ligand (which is encoded in humans by CXCL12 gene) and it induces an increased signaling and enhanced migration after stimulation by chemokine (Hernandez et al., 2003).”
BackgroundArnolds, K. L., & Spencer, J. V. (2014) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2014.04.018 · Cited by 38
“P A A uthor M anuscript receptor from being internalized, consequently preventing down-regulation following stimulation with ligand (Hernandez et al., 2003).”
InfluentialNakayama, T., Mutsuga, N., & Tosato, G. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk031 · Cited by 28
Chapter 2 CXCR4 and Mobilization of Hematopoietic Precursors
Rettig, M. P., Ramirez, P. A., Nervi, B., & DiPersio, J. F. (2009) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(09)05203-3 · Cited by 33
“Most cases of WHIM syndrome have been linked to autosomal dominant mutations in CXCR4, all of which truncate the C-terminal tail of CXCR4 (Balabanian et al., 2005b; Gulino et al., 2004; Hernandez et al., 2003).”
BackgroundAn Essential Role of the Cytoplasmic Tail of CXCR4 in G-Protein Signaling and Organogenesis
Cronshaw, D. G., Nie, Y., Waite, J. C., & Zou, Y.-R. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015397 · Cited by 30
Peng, D., Cao, B., Zhou, Y., & Long, Y. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.02.043 · Cited by 26
Raman, D., Neel, N. F., Sai, J., Mernaugh, R. L., Ham, A. L., & Richmond, A. J. (2009) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(09)05215-x · Cited by 26
“In some cases, there is a genetic alteration of chemokine receptors such as in WHIM syndrome (warts, hypogammaglobulinemia, infections, and myelokathexis) where CXCR4 is genetically altered at its C-terminus, resulting in a combined immunodeficiency disease (Hernandez et al., 2003).”
BackgroundRecurrent CXCR4 sequence variation in a girl with WHIM syndrome
Alapi, K. Z., Erdös, M., Kovács, G. E., & Maródi, L. (2006) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2006.00779.x · Cited by 26
“1016–1017delCT (S339fs342X) frame shift mutation were also reported to result in WHIM (4, 5).”
BackgroundGenetic variation in CXCL12 and risk of cervical carcinoma: a population‐based case–control study
Maley, S. N., Schwartz, S. M., Johnson, L., Malkki, M., Du, Q., Daling, J. R., Li, S. S., Zhao, L. P., Petersdorf, E. W., & Madeleine, M. M. (2009) · International Journal of Immunogenetics · doi:10.1111/j.1744-313x.2009.00877.x · Cited by 26
“…cellular responsiveness to CXCL12 have been shown by linkage analysis to underlie WHIM (warts, hypogammaglobulinemia, immunodeficiency and myelokatexis) syndrome, a rare immunodeficiency characterized by immune defects and extensive 6, 367–375 367 HPV-induced warts (Hernandez et al., 2003).”
BackgroundMeuris, F., Gaudin, F., Aknin, M.-L. R., Hémon, P., Berrebi, D. D., & Bachelerie, F. (2015) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2015.11.004 · Cited by 29
“, gain of function) are responsible for the rare warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM) syndrome (Hernandez et al., 2003).”
BackgroundVerma, R., & Marchese, A. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.606699 · Cited by 28
“This interaction is generally considered to be confined to the inner leaflet of the plasma membrane where PI3K catalyzes the conversion of phosphatidylinositol 4,5bisphosphate (PtdIns(4,5)P2) to phosphatidylinositol 3,4,5trisphosphate (PtdIns(3,4,5)P3) (13).”
BackgroundMethodInfluentialLaganà, M., Schlecht‐Louf, G., & Bachelerie, F. (2021) · Cells · doi:10.3390/cells10010075 · Cited by 26
“Early studies that have identified the role of CXCL12/CXCR4 in human immunodeficiency virus (HIV) pathogenesis [52,53], later in cancer progression and metastasis [54] and more recently in the pathogenesis of WHIM syndrome [55] have facilitated research devoted to the regulation of this signalling axis.”
BackgroundZehentmeier, S., Lim, V., Ma, Y., Fossati, J., Ito, T., Jiang, Y., Tumanov, A. V., Lee, H., Dillinger, L., Kim, J., et al. (2022) · Science Immunology · doi:10.1126/sciimmunol.abo3170 · Cited by 27
Autoimmune Neutropenias: Update on Clinical and Biological Features in Children and Adults
Fioredda, F., Dufour, C., Höglund, P., Papadaki, H. Α., & Palmblad, J. E. W. (2022) · HemaSphere · doi:10.1097/hs9.0000000000000814 · Cited by 25
Autosomal-dominant primary immunodeficiencies
Lawrence, T. C., Puel, A., Reichenbach, J., Ku, C., Chapgier, A. L. A., Renner, E. D., Minard-Colin, V., Ouache, M., & Casanova, J. (2004) · Current Opinion in Hematology · doi:10.1097/01.moh.0000149609.37309.0a · Cited by 27
Wang, L., Kuang, L., Hitron, J. A., Son, Y., Wang, X., Budhraja, A., Lee, J., Pratheeshkumar, P., Chen, G., Zhang, Z., et al. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.05.028 · Cited by 23
“Moreover, the CXCR4/ CXCL12 axis has also been related to leukocyte trafficking (Hernandez et al., 2003), B cell lymphopoiesis (Nagasawa et al.”
BackgroundGenetic Insights into Congenital Neutropenia
Klein, C., & Welte, K. (2009) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-009-8130-5 · Cited by 26
“Hernandez and colleagues [67] identified heterozygous”
Payne, D., Drinkwater, S., Baretto, R. L., Duddridge, M., & Browning, M. J. (2009) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2009.03889.x · Cited by 28
Tu, C. C., Arnolds, K. L., O’Connor, C. M., & Spencer, J. V. (2017) · Journal of Virology · doi:10.1128/jvi.01981-17 · Cited by 24
“However, regulation of CXCR4 activity is critical, and the congenital immunodeficiency syndrome warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM) results from increased CXCR4 signaling (93).”
BackgroundNeves, M. A. C., Simões, S., & Melo, M. L. S. E. (2010) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-010-9393-x · Cited by 23
Familial occurrence of warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM) syndrome
Siedlar, M., Rudzki, Z., Strach, M., Trzyna, E., Pituch‐Noworolska, A., Błaut-Szlósarczyk, A., Bukowska-Straková, K., Lenart, M., Grodzicki, T. K., & Zembala, M. (2008) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-008-0046-x · Cited by 23
“Neither the previously described [7] deletion of CT dinucleotide at position 1016-1017 nor a G→T change at position 1027 were found in the cDNA sequences.”
BackgroundInfluentialNeutropenia in primary immunodeficiency
Sokolic, R. (2013) · Current opinion in hematology · doi:10.1097/moh.0b013e32835aef1c · Cited by 22
A History of Pediatric Immunology
Stiehm, E. R., & Johnston, R. B. (2004) · Pediatric Research · doi:10.1203/01.pdr.0000151692.05422.4c · Cited by 24
Sanmun, D., Garwicz, D., Smith, C. I. E., Palmblad, J. E. W., & Fadeel, B. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06240.x · Cited by 23
“Subsequently, the observation of persistent hand warts and myelokathexis raised the possibility that she suffered from WHIM syndrome, a diagnosis that was confirmed by the identification of a previously reported CXCR4 gene mutation (S339fs342X) (Hernandez et al, 2003;”
BackgroundResultInfluentialCXCR4 has a dual role in improving the efficacy of BCMA-redirected CAR-NK cells in multiple myeloma
Moles, M. W., Erdlei, H., Menzel, L., Massaro, M., Fiori, A., Bunse, M., Schrimpf, M., Gerlach, K., Gudipati, V., Reiser, J., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1383136 · Cited by 30
Biallelic CXCR2 loss-of-function mutations define a distinct congenital neutropenia entity
Marin‐Esteban, V., Youn, J., Beaupain, B., Jaracz‐Ros, A., Barlogis, V., Fenneteau, O., Leblanc, T. M., Bellanger, F., Pellet, P., Buratti, J., et al. (2021) · Haematologica · doi:10.3324/haematol.2021.279254 · Cited by 24
“recurrent bacterial infections and myelokathexis reflecting an accumulation of senescent neutrophils in BM.(3) Profound neutropenia associated with myelokathexis was previously reported in two siblings carrying a homozygous truncating CXCR2 loss-of-function mutation, supporting the importance of CXCR2 signaling in neu…”
CD28 and chemokine receptors: Signalling amplifiers at the immunological synapse
Molon, B., Liboni, C., & Viola, A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.938004 · Cited by 24
“WHIM patients experience a wide range of symptoms, including recurring infections, human papillomavirus (HPV)-induced warts, reduced long-term immunoglobulin G (IgG) titers, myelokathexis, and leukopenia (107).”
BackgroundPrecision medicine: The use of tailored therapy in primary immunodeficiencies
Pinto, M. V., & Neves, J. F. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1029560 · Cited by 26
“WHIM is the result of an autosomal dominant GOF mutation in CXCR4, a chemokine receptor gene (65, 66).”
BackgroundDuquenne, C., Psomas, C. K., Gimenez, S., Guigues, A., Carles, M.-J., Barbuat, C., Lavigne, J., Sotto, A., Reynes, J., Guglielmi, P., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1303298 · Cited by 22
“Mutations in CXCR4 that increase its responsiveness to the chemokine ligand CXCL12 result in an immunodeficiency called WHIM (warts, hypogammaglobulinemia, infections, myelokathexis) syndrome (2).”
BackgroundBoeck, J. M., & Spencer, J. V. (2017) · PLoS ONE · doi:10.1371/journal.pone.0172042 · Cited by 23
Pillay, J., Tregay, N., Juzenaite, G., Carlin, L. M., Pirillo, C., Gaboriau, D. C. A., Farahi, N., Summers, C., Celso, C. L., Chilvers, E. R., et al. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.1ma0420-571rr · Cited by 22
Launay, O., Paul, S., Servettaz, A., Roguet, G., Rozenberg, F., Lucht, F., Lambert, C., Presles, É., Goulvestre, C., Méritet, J., et al. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.05.095 · Cited by 22
CXCR4 in Cancer and Its Regulation by PPARγ
Richard, C. L., & Blay, J. (2008) · PPAR Research · doi:10.1155/2008/769413 · Cited by 21
“Activating mutations of the CXCR4 gene lead to aberrant retention of myeloid cells within the bone marrow [19].”
BackgroundZmajkovicova, K., Pawar, S., Maier-Munsa, S., Maierhofer, B., Wiest, I., Skerlj, R. T., Taveras, A. G., & Badarau, A. (2022) · Genes and Immunity · doi:10.1038/s41435-022-00181-9 · Cited by 21
Clonal hematopoiesis in children with predisposing conditions
Attardi, E., Corey, S. J., & Włodarski, M. W. (2024) · Seminars in Hematology · doi:10.1053/j.seminhematol.2024.01.005 · Cited by 22
Understanding chronic neutropenia: life is short
Bartels, M., Murphy, K., Rieter, E., & Bruin, M. C. A. (2015) · British Journal of Haematology · doi:10.1111/bjh.13798 · Cited by 23
Chevigné, A., Fiévez, V., Szpakowska, M., Fischer, A., Counson, M., Plesséria, J., Schmit, J., & Deroo, S. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.01.017 · Cited by 22
Althof, N., & Whitton, J. L. (2012) · Journal of Virology · doi:10.1128/jvi.03004-12 · Cited by 23
“WHIM syndrome results from a dominant mutation in CXCR4 (76) which enhances CXCL12 signaling into neutro- phils, causing them to be retained in the BM, although they are released in relatively normal numbers in response to infection.”
BackgroundInfluentialOld and new faces of neutropenia in children
Dufour, C., Miano, M., & Fioredda, F. (2016) · Haematologica · doi:10.3324/haematol.2016.142760 · Cited by 21
Jiang, J. H., Jia, W.-H., Chen, H.-K., Feng, B., Qin, H.-D., Pan, Z. G., Shen, G.-P., Huang, L.-X., Feng, Q.-S., Chen, L.-Z., et al. (2004) · Journal of Translational Medicine · doi:10.1186/1479-5876-2-24 · Cited by 21
“A Nae I restriction site was created by introducing a G-C change at the 3'penultimate position of the forward primers for Exon 1F as described by Hernandez et al [21].”
MethodGenomic Landscape of Waldenström Macroglobulinemia
Treon, S. P., Xu, L., Liu, X., Hunter, Z. R., Yang, G., & Castillo, J. J. (2018) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2018.05.003 · Cited by 21
Clinical Validation of a CXCR4 Mutation Screening Assay for Waldenstrom Macroglobulinemia
Ballester, L. Y., Loghavi, S., Kanagal‐Shamanna, R., Barkoh, B. A., Lin, P., Medeiros, L. J., Luthra, R., & Patel, K. P. (2016) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2016.04.014 · Cited by 20
Roselli, G., Martini, E., Lougaris, V., Badolato, R., Viola, A., & Kallikourdis, M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01068 · Cited by 21
“Almost all cases of WHIM syndrome have been shown to be caused by dominant mutations in the last 10–19 amino acids of the carboxy-terminal domain (C-terminus) of the chemokine receptor CXCR4 (1, 2).”
BackgroundSDF-1-Enhanced Cardiogenesis Requires CXCR4 Induction in Pluripotent Stem Cells
Chiriac, A. E., Terzic, A., Park, S., Ikeda, Y., Faustino, R. S., & Nelson, T. J. (2010) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-010-9219-1 · Cited by 20
“Moreover, in adult life, the CXCR4/SDF-1 axis provides critical signaling for cell homing and intra-tissue retention, and defective stem cell migration leads to myelokathexis, a human deficiency syndrome described in patients harboring CXCR4 mutations [18].”
BackgroundCongenital neutropenia: From lab bench to clinic bedside and back
Dobrewa, W., Bielska, M., Bąbol‐Pokora, K., Janczar, S., & Mlynarski, W. M. (2023) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2023.108476 · Cited by 27
WHIM Syndrome-linked CXCR4 mutations drive osteoporosis
Anginot, A., Nguyen, J., Nader, Z. A., Rondeau, V., Bonaud, A., Kalogeraki, M., Boutin, A., Lemos, J. P., Bisio, V., Koenen, J., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37791-4 · Cited by 20
Oum, Y. H., Kell, S. A., Yoon, Y., Liang, Z., Burger, P. B., & Shim, H. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112479 · Cited by 19
“Among chemokine receptors, CXCR4 has rapidly emerged as an attractive therapeutic target because it is involved in the pathogenesis of various diseases including HIV-infection [5], rheumatoid arthritis [6], WHIM syndrome [7], inflammatory bowel disease [8], pulmonary fibrosis [9], lupus [10], and metastatic cancer [11…”
BackgroundAberrant CXCR4 Signaling at Crossroad of WHIM Syndrome and Waldenstrom’s Macroglobulinemia
Milanesi, S., Locati, M., & Borroni, E. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165696 · Cited by 19
“Studies have been conducted either in ex vivo setting using freshly isolated leukocytes (PBMC) or CD34+ cells from patients, and immortalized cells (EBV [48,49], BCWM.1 [50], MWCL‐1 [51] for WHIM and W , respectively), and in in vitro experimental settings using several cell lines (Table 1).”
BackgroundInfluentialBauer, T. R., Adler, R. L., & Hickstein, D. D. (2009) · ILAR Journal · doi:10.1093/ilar.50.2.168 · Cited by 23
“WHIM syndrome is caused by autosomal dominant mutations in the CXCR4 gene (Hernandez et al. 2003).”
BackgroundPrimary immunodeficiencies appearing as combined lymphopenia, neutropenia, and monocytopenia
Dotta, L., & Badolato, R. (2013) · Immunology Letters · doi:10.1016/j.imlet.2013.11.018 · Cited by 19
Isotype Specific Assembly of B Cell Antigen Receptors and Synergism With Chemokine Receptor CXCR4
Maity, P. C., Datta, M., Nicolò, A., & Jumaa, H. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02988 · Cited by 23
New Insights on the Emerging Genomic Landscape of CXCR4 in Cancer: A Lesson from WHIM
Scala, S., D’Alterio, C., Milanesi, S., Castagna, A., Carriero, R., Farina, F. M., Locati, M., & Borroni, E. M. (2020) · Vaccines · doi:10.3390/vaccines8020164 · Cited by 20
Kufareva, I., Stephens, B. S., Gilliland, C. T., Wu, B., Fenalti, G., Hamel, D. J., Stevens, R. C., Abagyan, R. A., & Handel, T. M. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-426-5_7 · Cited by 24
Gao, J., Yim, E., Siwicki, M. R., Yang, A. Y., Liu, Q., Azani, A. B., Owusu-Ansah, A., McDermott, D. H., & Murphy, P. M. (2018) · Journal of Clinical Investigation · doi:10.1172/jci120375 · Cited by 21
Encoding and decoding selectivity and promiscuity in the human chemokine-GPCR interaction network
Kleist, A. B., Szpakowska, M., Talbot, L. J., Slodkowicz, G., Malinverni, D., Thomas, M. A., Crawford, K. S., McGrail, D. J., Dishman, A. F., Wedemeyer, M. J., et al. (2025) · Cell · doi:10.1016/j.cell.2025.03.046 · Cited by 22
Neutrophils in cancer: At the crucial crossroads of anti‐tumor and pro‐tumor
Cai, W., Fan, T. T., Xiao, C., Deng, Z., Liu, Y., Li, C., & He, J. (2025) · 癌症:英文版 · doi:10.1002/cac2.70027 · Cited by 23
“Increased CXCR4 signaling results in a deficiency of neutrophils in circulation by promoting the accumulation of mature neutrophils in the bone marrow, while deletion of CXCR4 causes a shift in the pool of mature neutrophils from bone marrow to circulation [49, 50].”
Doncker, A., Balabanian, K., Bellanné‐Chantelot, C., de Guibert, S., Revest, M., Bachelerie, F., & Lamy, T. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03187.x · Cited by 17
“WHIM syndrome has been linked to impaired CXCR4 desensitization and internalization upon exposure to its ligand CXCL12 [4–9].”
BackgroundCXCR4 hyperactivation cooperates with TCL1 in CLL development and aggressiveness
Lewis, R. I., Maurer, H. C., Singh, N., González-Menéndez, I., Wirth, M., Schick, M., Zhang, L., Isaakidis, K., Scherger, A. K., Schulze, V., et al. (2021) · Leukemia · doi:10.1038/s41375-021-01376-1 · Cited by 17
Modulating vertebrate physiology by genomic fine-tuning of GPCR functions
Schöneberg, T. (2024) · Physiological Reviews · doi:10.1152/physrev.00017.2024 · Cited by 21
Resolution of Warts in Association with Subcutaneous Immunoglobulin in Immune Deficiency
Lin, J. H., Wang, K. Y., Kraft, S., & Roberts, R. L. (2009) · Pediatric Dermatology · doi:10.1111/j.1525-1470.2009.00874.x · Cited by 17
“There is a mutation in the chemokine receptor CXCR4 (7), which participates in several biologic processes including the development and function of lymphoid organs (8).”
BackgroundInherited Bone Marrow Failure Syndromes
Dror, Y. (2006) · Wiley eBooks · doi:10.1002/9780470987001.ch3 · Cited by 17
Genetics of severe congenital neutropenia as a gateway to personalized therapy
Donadieu, J., & Bellanné‐Chantelot, C. (2022) · Hematology · doi:10.1182/hematology.2022000392 · Cited by 16
ACKR3 in Skin Homeostasis, an Overlooked Player in the CXCR4/CXCL12 Axis
Margolles, G. C., Schlecht‐Louf, G., & Bachelerie, F. (2024) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2024.08.022 · Cited by 17
Myogenesis and molecules— insights from zebrafish Danio rerio
Chong, S. W., Korzh, V. P., & Jiang, Y. (2009) · Journal of Fish Biology · doi:10.1111/j.1095-8649.2009.02174.x · Cited by 19
Human Immunodeficiencies Related to Defective APC/T Cell Interaction
Kallikourdis, M., Viola, A., & Benvenuti, F. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00433 · Cited by 20
Molecular Classification of Primary Immunodeficiencies of T Lymphocytes
Comrie, W. A., & Lenardo, M. J. (2018) · Advances in immunology · doi:10.1016/bs.ai.2018.02.003 · Cited by 16
Family studies of warts, hypogammaglobulinemia, immunodeficiency, myelokathexis syndrome
Dale, D. C., Dick, E., Kelley, M. L., Makaryan, V., Connelly, J., & Bolyard, A. A. (2019) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000554 · Cited by 16
Age-related obesity and type 2 diabetes dysregulate neuronal associated genes and proteins in humans
Rahimi, M., Vinciguerra, M., Daghighi, S. M., Özcan, B., Akbarkhanzadeh, V., Sheedfar, F., Amini, M., Mazza, T., Pazienza, V., Motazacker, M. M., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4904 · Cited by 17
Rac signal adaptation controls neutrophil mobilization from the bone marrow
Campa, C. C., Germena, G., Ciraolo, E., Copperi, F., Sapienza, A., Franco, I., Ghigo, A., Camporeale, A., Savino, A. D., Martini, M., et al. (2016) · Science Signaling · doi:10.1126/scisignal.aah5882 · Cited by 14
“Alternatively, chronic noncyclic neutropenia observed in people affected by WHIM (warts, hypogammaglobulinemia, infections, and myelokathexis) syndrome, a congenital immunodeficiency disorder caused by an activating mutation of the CXCR4 receptor, causes abnormal susceptibility to human papilloma virus and recurrent i…”
BackgroundIdiopathic CD4+ lymphocytopenia and juvenile laryngeal papillomatosis
Pašić, S., Minic, P. B., Dzudovic, S., Minić, A., & Slavković, B. (2005) · Pediatric Pulmonology · doi:10.1002/ppul.20173 · Cited by 16
Chromothriptic cure of WHIM syndrome: Implications for bone marrow transplantation
McDermott, D. H., Gao, J., & Murphy, P. M. (2015) · Rare Diseases · doi:10.1080/21675511.2015.1073430 · Cited by 18
“WHIM syndrome is caused in almost all cases by mutations in the gene for the chemokine receptor CXCR4.(5) The syndrome is autosomal dominant and all known mutations are in the carboxy-terminus of the receptor in a region that encompasses negative regulatory elements.”
BackgroundBallesteros, I., & Hidalgo, A. (2025) · Cell · doi:10.1016/j.cell.2025.11.001 · Cited by 24
Li, W., Liu, C., Burns, N. G., Hayashi, J., Yoshida, A., Sajja, A. P., González-Hernández, S., Gao, J., Murphy, P. M., Kubota, Y., et al. (2021) · Developmental Biology · doi:10.1016/j.ydbio.2021.05.008 · Cited by 18
Chandrasekaran, P., Moore, V., Buckley, M. W., Spurrier, J. M., Kehrl, J. H., & Venkatesan, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086998 · Cited by 16
“Nef did not affect the poor internalization of the naturally occurring WHIM CXCR4 mutant [63,64,65] after agonist binding (Figure 1A1).”
Ephrin ligands and Eph receptors contribution to hematopoiesis
Tosato, G. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2566-1 · Cited by 15
Control of immune cell trafficking through inter-organ communication
Nakai, A., Leach, S., & Suzuki, K. (2021) · International Immunology · doi:10.1093/intimm/dxab009 · Cited by 14
Kumar, R., Milanesi, S., Szpakowska, M., Dotta, L., Silvestre, D. D., Trotta, A. M., Bello, A. M., Giacomelli, M., Benedito, M., Azevedo, J., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.145688 · Cited by 15
“Although WHIM syndrome was first described in 1964 (5), the association of CXCR4 mutations with this syndrome was only found in 2003 (6).”
BackgroundCXCR4 WHIM syndrome is a cancer predisposition condition for virus‐induced malignancies
Moulin, C., Beaupain, B., Suárez, F., Bertrand, Y., Beaussant, S. C., Fischer, A., Durin, J., Ranta, D., Espéli, M., Bachelerie, F., et al. (2024) · British Journal of Haematology · doi:10.1111/bjh.19373 · Cited by 14
Cellular stress pathways in pediatric bone marrow failure syndromes: many roads lead to neutropenia
Glaubach, T., Minella, A. C., & Corey, S. J. (2013) · Pediatric Research · doi:10.1038/pr.2013.197 · Cited by 14
Diagnostic Assays for Chronic Granulomatous Disease and Other Neutrophil Disorders
Elloumi, H. Z., & Holland, S. M. (2014) · Methods in molecular biology · doi:10.1007/978-1-62703-845-4_31 · Cited by 15
Biglari, S., Moghaddam, A. S., Tabatabaiefar, M. A., Sherkat, R., Youssefian, L., Saeidian, A. H., Vahidnezhad, F., Tsoi, L. C., Gudjonsson, J. E., Hakonarson, H. H., et al. (2023) · Genetics in Medicine · doi:10.1016/j.gim.2023.101028 · Cited by 19
Primary cutaneous follicle center lymphoma in a patient with WHIM syndrome
Yoshii, Y., Kato, T., Ono, K., Takahashi, E., Fujimoto, N., Kobayashi, S., Kimura, F., Nonoyama, S., & Satoh, T. (2015) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.12927 · Cited by 13
Cutolo, P., Basdevant, N., Bernadat, G., Bachelerie, F., & Ha‐Duong, T. (2016) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2016.1145142 · Cited by 13
“, 2008) in the context of the rare WHIM disorder associated with heterozygous CXCR4 mutations (Hernandez et al., 2003).”
BackgroundHaukioja, A. L., Tervahartiala, T. I., Sorsa, T. A., & Syrjänen, S. (2017) · Journal of Clinical Virology · doi:10.1016/j.jcv.2017.10.011 · Cited by 13
Bezzerri, V., Api, M., Allegri, M., Fabrizzi, B., Corey, S. J., & Cipolli, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134672 · Cited by 13
Chudziak, D., Spohn, G., Karpova, D., Dauber, K., Wiercinska, E., Miettinen, J. A., Papayannopoulou, T., & Bonig, H. B. (2014) · Stem Cells and Development · doi:10.1089/scd.2014.0284 · Cited by 15
Chemoattractant receptors as pharmacological targets for elimination of glioma stem-like cells
Yao, X., Liu, Y., Chen, K., Gong, W., Liu, M., Bian, X., & Wang, J. M. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2011.08.021 · Cited by 14
Metadata
- Authors
- Hernandez, P. A., Gorlin, R. J., Lukens, J. N., Taniuchi, S., Bohinjec, J., Francois, F., Klotman, M. E., & Diaz, G. A.
- Affiliations
- Icahn School of Medicine at Mount Sinai (US)
- University of Minnesota (US)
- Vanderbilt University (US)
- Kansai Medical University (JP)
- Ljubljana University Medical Centre (SI)
- Venue
- Nature Genetics
- Published
- 2003-04-14
- Volume
- 34
- Issue
- 1
- Pages
- 70-74
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2167070743
- Cited by
- 722
- References
- 30
- Citations by year
- 2026: 11 · 2025: 20 · 2024: 40 · 2023: 26 · 2022: 21 · 2021: 25 · 2020: 33 · 2019: 38 · 2018: 39 · 2017: 37 · 2016: 34 · 2015: 37 · 2014: 48 · 2013: 32 · 2012: 35
- FWCI
- 8.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Health Sciences › Medicine › Hematology › Blood disorders and treatments
- Keywords
- WHIM syndrome, CXCR4, myelokathexis, combined immunodeficiency, neutropenia, hypogammaglobulinemia, HPV infection, calcium flux, autosomal recessive inheritance, genetic heterogeneity, cell-mediated immunity
- MeSH terms
- Agammaglobulinemia, B-Lymphocytes, Base Sequence, Chromosomes, Human, Pair 2, DNA, DNA Mutational Analysis, Female, Humans, Immunologic Deficiency Syndromes, Genetic Linkage, Male, Models, Molecular, Molecular Sequence Data, Mutation, Neutropenia, Pedigree, Warts, Receptors, CXCR4, Calcium Signaling
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.